Results: 18
Population attributable fractions continue to unmask the power of prevention.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Germline mutations as potential causes of childhood solid tumours: comments on the Norwegian childhood cancer cohort study.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reply to 'Comment on 'BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses''.
- Published in:
- 2018
- By:
- Publication type:
- Letter
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.
- Published in:
- British Journal of Cancer, 2018, v. 118, n. 8, p. 1051, doi. 10.1038/s41416-018-0026-9
- By:
- Publication type:
- Article
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A shift from papillary to reticular fibroblasts enables tumour-stroma interaction and invasion.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comment on 'BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses'.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
- Published in:
- British Journal of Cancer, 2018, v. 118, n. 8, p. 1123, doi. 10.1038/s41416-018-0011-3
- By:
- Publication type:
- Article
A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article